Renal effects and safety between Asian and non-Asian chronic kidney disease and type 2 diabetes treated with nonsteroidal mineralocorticoid antagonists.

Xiaoming XuJing FengYuying CuiPingjiang LiJianjun DongJianjun Dong

Published in: Journal of diabetes (2024)

Nonsteroidal MRAs exhibited significant renal benefits by decreasing UACR and lowering SBP in Asian than that of non-Asian patients with CKD and T2DM, without increase of adverse events except hyperkalemia and eGFR decrease ≥30%.

Keyphrases

chronic kidney disease
type diabetes
end stage renal disease
small cell lung cancer
glycemic control
epidermal growth factor receptor
tyrosine kinase
metabolic syndrome
skeletal muscle
weight loss
newly diagnosed